Correlations among improvements in urgency urinary incontinence health-related quality of life and perception of bladder-related problems in incontinent subjects with overactive bladder treated with tolterodine or placebo

摘要

BackgroundPrevious studies demonstrate that tolterodine extended release (ER) significantly improves urgency urinary incontinence (UUI) episodes. Instruments that measure patient-reported outcomes (PROs) provide additional information that is valuable for assessing whether clinical improvements are meaningful to the patient. This study determined the correlation of changes in bladder diary variables and other PROs in subjects with overactive bladder (OAB).